Lalit Kumar Gupta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lalit Kumar Gupta has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
Asit Mittal
Department of Dermatology, Rabindranath Tagore Medical College, Udaipur, Rajasthan, India
24 shared publicationsManisha Balai
Department of Dermatology, RNT Medical College, Udaipur, Rajasthan, India
21 shared publicationsSharad Mehta
Department of Dermatology, Venereology and Leprosy, R.N.T. Medical College, Udaipur, Rajasthan, India
15 shared publicationsAshok Kumar Khare
Department of Dermatology, Venereology and Leprosy, R.N.T. Medical College, Udaipur, Rajasthan, India
12 shared publicationsAshokKumar Khare
Department of Dermatology, Venereology and Leprosy, RNT Medical College, Udaipur, Rajasthan, India
6 shared publicationsAnkita Srivastava
5 shared publications
Latest Publications
- Open Access
- 1 July 2026
- Published by Wolters Kluwer Health in Indian Journal of Paediatric Dermatology
- Vol. 27 (3) , 185-189
Clinico-epidemiological Spectrum of Childhood Vitiligo at a Tertiary Care Center of South Rajasthan
Background: Vitiligo is an acquired, multifactorial disorder of depigmentation and has serious psychological impact. Childhood vitiligo has different characteristics as compared to adult-onset vitiligo. Aims and Objective: To evaluate the burden and clinical characteristics of childhood vitiligo (age ≤18 years) attending skin outpatient department (OPD) and association with other autoimmune diseases. Materials and Methods: A cross-sectional hospital-based study of 152 childhood vitiligo cases (aged ≤18 years) attending dermatology OPD of a tertiary health care center of South Rajasthan for 1 year. After obtaining informed consent and a detailed history, cutaneous, general and systemic examination was performed and relevant investigations were carried out. Data analysis was done using the SPSS software version 16.0 and Microsoft Excel. Result: Of the total 152 patients, females outnumbered males and the M:F ratio was 1:1.53. The mean age at the presentation was 11.82 years and the mean age of onset of vitiligo was 9.78 ± 3.60 years with the mean duration of disease was 1.96 ± 1.99 years. The most common type was generalized vitiligo (67.8%) followed by segmental vitiligo (17.1%). The most common site of onset of vitiligo was eyelid. Positive family history was seen in 17 (11.18%) patients. Leukotrichia was seen in 21% of patients. Majority of patients had Vitiligo Area Scoring Index (VASI) <10 and children with the positive family history of vitiligo had higher mean VASI than those with a negative family history of vitiligo, which was statistically not significant. Conclusion: A female preponderance with prominent involvement of eyelids as the initial and most common site of affection was seen in our study.
- 1 July 2026
- Published by Wolters Kluwer Health in Indian Journal of Paediatric Dermatology
- Vol. 27 (3) , 185-189
Open AccessClinico-epidemiological Spectrum of Childhood Vitiligo at a Tertiary Care Center of South Rajasthan
Background: Vitiligo is an acquired, multifactorial disorder of depigmentation and has serious psychological impact. Childhood vitiligo has different characteristics as compared to adult-onset vitiligo. Aims and Objective: To evaluate the burden and clinical characteristics of childhood vitiligo (age ≤18 years) attending skin outpatient department (OPD) and association with other autoimmune diseases. Materials and Methods: A cross-sectional hospital-based study of 152 childhood vitiligo cases (aged ≤18 years) attending dermatology OPD of a tertiary health care center of South Rajasthan for 1 year. After obtaining informed consent and a detailed history, cutaneous, general and systemic examination was performed and relevant investigations were carried out. Data analysis was done using the SPSS software version 16.0 and Microsoft Excel. Result: Of the total 152 patients, females outnumbered males and the M:F ratio was 1:1.53. The mean age at the presentation was 11.82 years and the mean age of onset of vitiligo was 9.78 ± 3.60 years with the mean duration of disease was 1.96 ± 1.99 years. The most common type was generalized vitiligo (67.8%) followed by segmental vitiligo (17.1%). The most common site of onset of vitiligo was eyelid. Positive family history was seen in 17 (11.18%) patients. Leukotrichia was seen in 21% of patients. Majority of patients had Vitiligo Area Scoring Index (VASI) <10 and children with the positive family history of vitiligo had higher mean VASI than those with a negative family history of vitiligo, which was statistically not significant. Conclusion: A female preponderance with prominent involvement of eyelids as the initial and most common site of affection was seen in our study.
- Open Access
- 14 April 2026
- Published by Wolters Kluwer Health in Indian Dermatology Online Journal
- Vol. 17 (3) , 374-379
A Demographic and Biochemical Profile of Patients with Premature Graying of Hair (Canities) at a Tertiary Care Centre: A Case–Control Study
Background: Premature graying of hair (PGH) is a significant concern for individuals, as it is frequently perceived as an indicator of advancing age and reduced vitality, and can lead to lower self-esteem and psychological distress. Deficiencies of vitamin B12, vitamin D3 and ferritin may be related to PGH. Nevertheless, data on the specific risk factors and biochemical parameters for PGH in India are relatively limited. Aim and Objective: This study was conducted to examine the various demographic and potential risk factors, along with biochemical variables linked to PGH. Patients and Methods: An analytical case–control study was conducted on patients attending the skin outpatient department with PGH. The control group comprised age- and gender-matched patients and attendants with other dermatoses. Various demographic factors and potential risk factors were documented and compared with control groups. Measurement of serum ferritin, calcium, hemoglobin, vitamin D3, vitamin B12, lipid profile, and thyroid profile was done and analyzed between the cases and controls. Results: Males outnumbered females with a male-to-female ratio of 1.5:1. Most of the cases of PGH belonged to the age group of 15–25 years (71.5%). On binary multivariate regression analysis, statistically significant differences in family history, smoking and hair plucking compared to controls were noted. Additionally, the cases had considerably lower levels of serum ferritin ( P = 0.020), vitamin B12 ( P = 0.012), and vitamin D3 ( P = 0.043). Limitations: This study was done at a single center. We plan to conduct a multicentric study in the future. Recall bias may also be a limitation in the study. The patients were not followed-up after correction to assess it’s effect. Conclusion: Identifying modifiable risk factors and correcting biochemical abnormalities may help in preventing and better managing patients with PGH.
- 14 April 2026
- Published by Wolters Kluwer Health in Indian Dermatology Online Journal
- Vol. 17 (3) , 374-379
Open AccessA Demographic and Biochemical Profile of Patients with Premature Graying of Hair (Canities) at a Tertiary Care Centre: A Case–Control Study
Background: Premature graying of hair (PGH) is a significant concern for individuals, as it is frequently perceived as an indicator of advancing age and reduced vitality, and can lead to lower self-esteem and psychological distress. Deficiencies of vitamin B12, vitamin D3 and ferritin may be related to PGH. Nevertheless, data on the specific risk factors and biochemical parameters for PGH in India are relatively limited. Aim and Objective: This study was conducted to examine the various demographic and potential risk factors, along with biochemical variables linked to PGH. Patients and Methods: An analytical case–control study was conducted on patients attending the skin outpatient department with PGH. The control group comprised age- and gender-matched patients and attendants with other dermatoses. Various demographic factors and potential risk factors were documented and compared with control groups. Measurement of serum ferritin, calcium, hemoglobin, vitamin D3, vitamin B12, lipid profile, and thyroid profile was done and analyzed between the cases and controls. Results: Males outnumbered females with a male-to-female ratio of 1.5:1. Most of the cases of PGH belonged to the age group of 15–25 years (71.5%). On binary multivariate regression analysis, statistically significant differences in family history, smoking and hair plucking compared to controls were noted. Additionally, the cases had considerably lower levels of serum ferritin ( P = 0.020), vitamin B12 ( P = 0.012), and vitamin D3 ( P = 0.043). Limitations: This study was done at a single center. We plan to conduct a multicentric study in the future. Recall bias may also be a limitation in the study. The patients were not followed-up after correction to assess it’s effect. Conclusion: Identifying modifiable risk factors and correcting biochemical abnormalities may help in preventing and better managing patients with PGH.
- Open Access
- 9 September 2025
- Published by Wolters Kluwer Health in Indian Dermatology Online Journal
- Vol. 17 (1) , 105-106
Generalized Lichen Nitidus Successfully Treated with Cyclosporine
- 9 September 2025
- Published by Wolters Kluwer Health in Indian Dermatology Online Journal
- Vol. 17 (1) , 105-106
Open AccessGeneralized Lichen Nitidus Successfully Treated with Cyclosporine
- Open Access
- 20 August 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (8) , 844
PRACT-India: Practical Recommendations on Acne Care and Medical Treatment in India—A Modified Delphi Consensus
Background/Objectives: Acne vulgaris is a prevalent dermatological condition, yet clear, region-specific management guidelines, particularly for India’s diverse population, remain limited. Effective acne management extends beyond pharmacologic therapy, emphasizing proper skincare, patient education, and adherence strategies. This consensus aims to provide tailored, evidence-based recommendations for optimizing acne treatment in the Indian context. Methods: A panel of 14 dermatology experts with ≥15 years of experience reviewed literature, real-world clinical practices, and patient-centric factors relevant to acne management in India. Using a modified Delphi process with two virtual voting rounds, 61 statements across seven clinical domains were evaluated. Consensus was defined as ≥75% agreement. Results: Topical retinoids remain the first-line therapy, with combination regimens (benzoyl peroxide or topical antibiotics) preferred to enhance efficacy and minimize antibiotic resistance. Hormonal therapies, including combined oral contraceptives and spironolactone, are recommended for females with resistant acne. Guidance includes individualized treatment plans, baseline investigations, and selection of appropriate topical and systemic agents. Special considerations for pregnancy and lactation prioritize maternal and fetal safety. Conclusions: This expert consensus provides practical, evidence-based recommendations for acne management in India, integrating pharmacological and non-pharmacological approaches. The tailored guidance supports individualized care, antibiotic stewardship, and improved treatment adherence, aiming to enhance patient outcomes nationwide.
- 20 August 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (8) , 844
Open AccessPRACT-India: Practical Recommendations on Acne Care and Medical Treatment in India—A Modified Delphi Consensus
Background/Objectives: Acne vulgaris is a prevalent dermatological condition, yet clear, region-specific management guidelines, particularly for India’s diverse population, remain limited. Effective acne management extends beyond pharmacologic therapy, emphasizing proper skincare, patient education, and adherence strategies. This consensus aims to provide tailored, evidence-based recommendations for optimizing acne treatment in the Indian context. Methods: A panel of 14 dermatology experts with ≥15 years of experience reviewed literature, real-world clinical practices, and patient-centric factors relevant to acne management in India. Using a modified Delphi process with two virtual voting rounds, 61 statements across seven clinical domains were evaluated. Consensus was defined as ≥75% agreement. Results: Topical retinoids remain the first-line therapy, with combination regimens (benzoyl peroxide or topical antibiotics) preferred to enhance efficacy and minimize antibiotic resistance. Hormonal therapies, including combined oral contraceptives and spironolactone, are recommended for females with resistant acne. Guidance includes individualized treatment plans, baseline investigations, and selection of appropriate topical and systemic agents. Special considerations for pregnancy and lactation prioritize maternal and fetal safety. Conclusions: This expert consensus provides practical, evidence-based recommendations for acne management in India, integrating pharmacological and non-pharmacological approaches. The tailored guidance supports individualized care, antibiotic stewardship, and improved treatment adherence, aiming to enhance patient outcomes nationwide.
- Open Access
- 24 November 2023
- Published by Medknow in Indian Dermatology Online Journal
- Vol. 15 (2) , 358-359
Angiolymphoid Hyperplasia with Eosinophilia
- 24 November 2023
- Published by Medknow in Indian Dermatology Online Journal
- Vol. 15 (2) , 358-359
Open AccessAngiolymphoid Hyperplasia with Eosinophilia
- Open Access
- 6 June 2023
- Published by Wolters Kluwer Health in Asia Pacific Allergy
- Vol. 13 (2) , 60-65
Management of hereditary angioedema in resource-constrained settings: A consensus statement from Indian subcontinent
Hereditary angioedema (HAE) is an uncommon disorder characterized clinically by recurrent episodes of nonitchy subcutaneous and/or submucosal swellings. The estimated prevalence of HAE is ~ 1: 10,000 to 1: 50,000. There are no prevalence data from India, however, estimates suggest that there are 27,000 to 135,000 patients with HAE in India at present. The majority of these, however, remain undiagnosed. Replacement of plasma-derived or recombinant C1-esterase inhibitor (C1-INH) protein, administered intravenously, is the treatment of choice during the management of acute episodes of angioedema (i.e., “on-demand treatment”) and is also useful for short-term prophylaxis (STP) and long-term prophylaxis (LTP). This has been found to be effective and safe even in young children and during pregnancy. Until recently, none of the first-line treatment options were available for “on-demand treatment,” STP or LTP in India. As a result, physicians had to use fresh frozen plasma for both “on-demand treatment” and STP. For LTP, attenuated androgens (danazol or stanozolol) and/or tranexamic acid were commonly used. These drugs have been reported to be useful for LTP but are associated with a significant risk of adverse effects. Intravenous pd-C1-INH, the first-line treatment option, is now available in India. However, because there is no universal health insurance, access to pd-C1-INH is a significant challenge. HAE Society of India has developed these consensus guidelines for India and other resource-constrained settings where plasma-derived C1-INH therapy is the only available first-line treatment option for the management of HAE and diagnostic facilities are limited. These guidelines have been developed because it may not be possible for all patients to access the recommended therapy and at the recommended doses as suggested by the international guidelines. Moreover, it may not be feasible to follow the evaluation algorithm suggested by the international guidelines.
- 6 June 2023
- Published by Wolters Kluwer Health in Asia Pacific Allergy
- Vol. 13 (2) , 60-65
Open AccessManagement of hereditary angioedema in resource-constrained settings: A consensus statement from Indian subcontinent
Hereditary angioedema (HAE) is an uncommon disorder characterized clinically by recurrent episodes of nonitchy subcutaneous and/or submucosal swellings. The estimated prevalence of HAE is ~ 1: 10,000 to 1: 50,000. There are no prevalence data from India, however, estimates suggest that there are 27,000 to 135,000 patients with HAE in India at present. The majority of these, however, remain undiagnosed. Replacement of plasma-derived or recombinant C1-esterase inhibitor (C1-INH) protein, administered intravenously, is the treatment of choice during the management of acute episodes of angioedema (i.e., “on-demand treatment”) and is also useful for short-term prophylaxis (STP) and long-term prophylaxis (LTP). This has been found to be effective and safe even in young children and during pregnancy. Until recently, none of the first-line treatment options were available for “on-demand treatment,” STP or LTP in India. As a result, physicians had to use fresh frozen plasma for both “on-demand treatment” and STP. For LTP, attenuated androgens (danazol or stanozolol) and/or tranexamic acid were commonly used. These drugs have been reported to be useful for LTP but are associated with a significant risk of adverse effects. Intravenous pd-C1-INH, the first-line treatment option, is now available in India. However, because there is no universal health insurance, access to pd-C1-INH is a significant challenge. HAE Society of India has developed these consensus guidelines for India and other resource-constrained settings where plasma-derived C1-INH therapy is the only available first-line treatment option for the management of HAE and diagnostic facilities are limited. These guidelines have been developed because it may not be possible for all patients to access the recommended therapy and at the recommended doses as suggested by the international guidelines. Moreover, it may not be feasible to follow the evaluation algorithm suggested by the international guidelines.
- Open Access
- 1 January 2023
- Published by Medknow in Indian Dermatology Online Journal
- Vol. 14 (2) , 284-286
A squamous cell carcinoma presenting as a giant cutaneous horn over the lower lip in a patient with chronic disseminated lupus erythematosus
- 1 January 2023
- Published by Medknow in Indian Dermatology Online Journal
- Vol. 14 (2) , 284-286
Open AccessA squamous cell carcinoma presenting as a giant cutaneous horn over the lower lip in a patient with chronic disseminated lupus erythematosus
- Open Access
- 1 January 2023
- Published by Medknow in Indian Dermatology Online Journal
- Vol. 14 (2) , 306
Trigeminal trophic syndrome
- 1 January 2023
- Published by Medknow in Indian Dermatology Online Journal
- Vol. 14 (2) , 306
Open AccessTrigeminal trophic syndrome
- Open Access
- 1 May 2022
- Published by Medknow in Indian Journal of Dermatology
- Vol. 67 (3) , 317
Linear fixed drug eruptions to Levofloxacin
Published on behalf of INDIAN ASSOCIATION OF DERMATOLOGISTS, VENEREOLOGISTS AND LEPROLOGISTS, WEST BENGAL STATE BRANCH.
- 1 May 2022
- Published by Medknow in Indian Journal of Dermatology
- Vol. 67 (3) , 317
Open AccessLinear fixed drug eruptions to Levofloxacin
Published on behalf of INDIAN ASSOCIATION OF DERMATOLOGISTS, VENEREOLOGISTS AND LEPROLOGISTS, WEST BENGAL STATE BRANCH.
- Open Access
- 2 March 2021
- Published by Scientific Scholar in Indian Journal of Dermatology, Venereology and Leprology
- Vol. 87 (3) , 402-404
Carbamazepine-induced linear and bullous fixed drug eruption representing Wolf ’s isotopic phenomenon
- 2 March 2021
- Published by Scientific Scholar in Indian Journal of Dermatology, Venereology and Leprology
- Vol. 87 (3) , 402-404
Open AccessCarbamazepine-induced linear and bullous fixed drug eruption representing Wolf ’s isotopic phenomenon